Combination immunotherapy targets cancer resistance – Yale News
Yale News |
Combination immunotherapy targets cancer resistance
Yale News Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this problem by targeting a … |
